India Pivots on NDM-1

The Times of India reports that India’s National Centre for Disease Control is initiating a study intended to assess the prevalence of Carbapenem (a class of antibiotics) resistance within hospital settings and in the environment.  The sixth month-long study is scheduled to begin in May.  It will examine all intensive care unit admissions in three New Delhi-based hospitals.  Additional hospitals outside New Delhi might also participate in the study.  In addition, water samples will be taken from the environment surrounding the hospitals and tested for drug-resistant bacteria.  Initiation of this study suggests a shift in India’s policy response to the detection of NDM-1 in clinical settings and local water supplies.

PDF24    Send article as PDF